Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Edaravone Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Edaravone Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Oral
      • 1.3.3 Injection
    • 1.4 Market Segment by Application
      • 1.4.1 Global Edaravone Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinic
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Edaravone Market Size
      • 2.1.1 Global Edaravone Revenue 2014-2025
      • 2.1.2 Global Edaravone Sales 2014-2025
    • 2.2 Edaravone Growth Rate by Regions
      • 2.2.1 Global Edaravone Sales by Regions 2014-2019
      • 2.2.2 Global Edaravone Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Edaravone Sales by Manufacturers
      • 3.1.1 Edaravone Sales by Manufacturers 2014-2019
      • 3.1.2 Edaravone Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Edaravone Revenue by Manufacturers (2014-2019)
      • 3.2.2 Edaravone Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Edaravone Market Concentration Ratio (CR5 and HHI)
    • 3.3 Edaravone Price by Manufacturers
    • 3.4 Key Manufacturers Edaravone Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Edaravone Market
    • 3.6 Key Manufacturers Edaravone Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Oral Sales and Revenue (2014-2019)
      • 4.1.2 Injection Sales and Revenue (2014-2019)
    • 4.2 Global Edaravone Sales Market Share by Type
    • 4.3 Global Edaravone Revenue Market Share by Type
    • 4.4 Edaravone Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Edaravone Sales by Application

    6 United States

    • 6.1 United States Edaravone Breakdown Data by Company
    • 6.2 United States Edaravone Breakdown Data by Type
    • 6.3 United States Edaravone Breakdown Data by Application

    7 European Union

    • 7.1 European Union Edaravone Breakdown Data by Company
    • 7.2 European Union Edaravone Breakdown Data by Type
    • 7.3 European Union Edaravone Breakdown Data by Application

    8 China

    • 8.1 China Edaravone Breakdown Data by Company
    • 8.2 China Edaravone Breakdown Data by Type
    • 8.3 China Edaravone Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Edaravone Breakdown Data by Company
    • 9.2 Rest of World Edaravone Breakdown Data by Type
    • 9.3 Rest of World Edaravone Breakdown Data by Application
    • 9.4 Rest of World Edaravone Breakdown Data by Countries
      • 9.4.1 Rest of World Edaravone Sales by Countries
      • 9.4.2 Rest of World Edaravone Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Mitsubishi Tanabe Pharma
      • 10.1.1 Mitsubishi Tanabe Pharma Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Edaravone
      • 10.1.4 Edaravone Product Introduction
      • 10.1.5 Mitsubishi Tanabe Pharma Recent Development
    • 10.2 Simcere
      • 10.2.1 Simcere Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Edaravone
      • 10.2.4 Edaravone Product Introduction
      • 10.2.5 Simcere Recent Development
    • 10.3 Taj Pharmaceuticals Ltd.
      • 10.3.1 Taj Pharmaceuticals Ltd. Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Edaravone
      • 10.3.4 Edaravone Product Introduction
      • 10.3.5 Taj Pharmaceuticals Ltd. Recent Development
    • 10.4 Sun Pharmaceutical Industries Ltd.
      • 10.4.1 Sun Pharmaceutical Industries Ltd. Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Edaravone
      • 10.4.4 Edaravone Product Introduction
      • 10.4.5 Sun Pharmaceutical Industries Ltd. Recent Development
    • 10.5 Unichem Laboratories Ltd
      • 10.5.1 Unichem Laboratories Ltd Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Edaravone
      • 10.5.4 Edaravone Product Introduction
      • 10.5.5 Unichem Laboratories Ltd Recent Development
    • 10.6 UCB India Ltd
      • 10.6.1 UCB India Ltd Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Edaravone
      • 10.6.4 Edaravone Product Introduction
      • 10.6.5 UCB India Ltd Recent Development
    • 10.7 Piramal Healthcare
      • 10.7.1 Piramal Healthcare Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Edaravone
      • 10.7.4 Edaravone Product Introduction
      • 10.7.5 Piramal Healthcare Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Edaravone Sales Channels
      • 11.2.2 Edaravone Distributors
    • 11.3 Edaravone Customers

    12 Market Forecast

    • 12.1 Global Edaravone Sales and Revenue Forecast 2019-2025
    • 12.2 Global Edaravone Sales Forecast by Type
    • 12.3 Global Edaravone Sales Forecast by Application
    • 12.4 Edaravone Forecast by Regions
      • 12.4.1 Global Edaravone Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Edaravone Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Edaravone is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Edaravone.

      This report studies the global market size of Edaravone, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Edaravone sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Mitsubishi Tanabe Pharma
      Simcere
      Taj Pharmaceuticals Ltd.
      Sun Pharmaceutical Industries Ltd.
      Unichem Laboratories Ltd
      UCB India Ltd
      Piramal Healthcare
      ...

      Market Segment by Product Type
      Oral
      Injection

      Market Segment by Application
      Hospital
      Clinic
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Edaravone status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Edaravone manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Edaravone are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now